Pharvaris (PHVS) Capital Expenditures (QoQ) (2020 - 2026)
Pharvaris (PHVS) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,306.82% |
| Dec 31, 2025 | 91.82% |
| Sep 30, 2025 | -216.18% |
| Jun 30, 2025 | 111.12% |
| Mar 31, 2025 | 1.51% |
| Dec 31, 2024 | 48.89% |
| Sep 30, 2024 | -678.34% |
| Jun 30, 2024 | -29.56% |
| Mar 31, 2024 | -9.25% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | 199.97% |
| Jun 30, 2023 | -288,368,412.67% |
| Mar 31, 2023 | 15.27% |
| Dec 31, 2022 | 53.02% |
| Sep 30, 2022 | -105.90% |
| Jun 30, 2022 | 15.76% |
| Mar 31, 2022 | 62.25% |
| Dec 31, 2021 | -137.96% |
| Sep 30, 2021 | -16.48% |
| Jun 30, 2021 | -132.99% |